상세 정보

underline
Metadata Downloads : dc(xml) or Excel
Cited 0 time in scopus ci

Title 

Immunohistochemical characterization of cutaneous drug eruptions by STI571

Authors 

H J ParkH S KimH J KimJ Y LeeB K ChoA W LeeDo Young YoonD H Cho

Publisher 

Elsevier

Issue Date 

2005

Citation 

Journal of Dermatological Science, vol. 38, no. 1, pp. 9-15

Keywords 

CMLdrug eruptionICAM-1IL-1βIL-18STI571drug eruptions

Abstract 

Background: STI571, a selective BCR-ABL tyrosine kinase inhibitor, is a promising new drug for chronic myelogenous leukemia (CML). However, the drug has been reported to be associated with adverse cutaneous drug eruptions with high frequency. Objective: In this study, the characteristics of the cutaneous drug eruptions by STI571 were investigated. Methods: The clinical records of 10 patients diagnosed with drug eruption by STI571 were reviewed. We obtained 10 skin biopsy specimens from patients with drug eruption by STI571, 6 from the antibiotics-induced drug eruption group, and 5 from normal skin (control). Immunohistochemical analysis was performed to detect CD4, CD8, CD56, IL-18, IL-1β and ICAM-1 expression in the cutaneous drug eruption. Results: Seven out of 10 patients had maculopapular exanthema, 2/10 erythema multiforme, 1/10 urticaria. We analyzed the composition of T-lymphocyte subsets from the infiltrates at the STI571-induced drug eruption site in eight patients. Unlike other drug eruptions, the increase in the CD8 expression was statistically significant, especially in the dermoepidermal junction and the upper dermis (P < 0.01). The enhanced expression of IL-18 and IL-1β was observed as well. In contrast, ICAM-1 was either weakly positive or negative. Conclusion: Drug eruption caused by STI571 was mostly expressed as a maculopapular exanthema. The histopathological findings were similar in drug eruption by antibiotics or STI571. Unlike the drug eruptions caused by antibiotics, where the expression of CD4 was dominant, CD8 was dominant in drug eruptions by STI571. The expression of IL-18 and IL-1β was increased in both groups. This elevation of IL-18 and IL-1β may assist in understanding the pathogenesis of cutaneous drug eruption.

ISSN 

0923-1811

Link 

http://dx.doi.org/10.1016/j.jdermsci.2004.12.002

Appears in Collections

1. Journal Articles > Journal Articles

Registered Date

2017-04-19


There are no files associated with this item.
qrcode

FusionCharts.
DSpace Software Coptright(c) 2010 MIT and Hewleft-Packard  /  KRIBB-REPOSITORY ( Email:jakim@kribb.re.kr)